Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Redcare Pharmacy NV's Enterprise Value is CHF1,390 Mil.
Redcare Pharmacy NV's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was CHF-6 Mil. Therefore, Redcare Pharmacy NV's EV-to-OCF for today is -231.95.
The historical rank and industry rank for Redcare Pharmacy NV's EV-to-OCF or its related term are showing as below:
XSWX:RDC'
s EV-to-OCF Range Over the Past 10 Years
Min: -294.96 Med: -11.37 Max: 1393.55
Current: -259.74
During the past 13 years, the highest EV-to-OCF of Redcare Pharmacy NV was 1393.55. The lowest was -294.96. And the median was -11.37.
XSWX:RDC's EV-to-OCF is ranked better than 98.68% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 8.8
vs XSWX:RDC: -259.74
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Redcare Pharmacy NV's PE Ratio (TTM) for today is calculated as:
Redcare Pharmacy NV's share price for today is CHF58.05.
Redcare Pharmacy NV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-1.941.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Redcare Pharmacy NV EV-to-OCF Related Terms
Redcare Pharmacy NV EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Redcare Pharmacy NV's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Redcare Pharmacy NV's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Redcare Pharmacy NV EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Redcare Pharmacy NV's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Redcare Pharmacy NV's EV-to-OCF falls into.
Redcare Pharmacy NV's current Enterprise Value is CHF1,390 Mil.
Redcare Pharmacy NV's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Redcare Pharmacy NV (XSWX:RDC) has a EV-to-OCF of -231.95 as of Aug. 16, 2026. According to the industry distribution chart, Redcare Pharmacy NV ranks #9 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 1.3%.
Is Redcare Pharmacy NV's EV-to-OCF too high?
Redcare Pharmacy NV's current EV-to-OCF is -231.95. Based on the distribution chart, Redcare Pharmacy NV ranks #9 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Redcare Pharmacy NV has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Redcare Pharmacy NV's EV-to-OCF compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Redcare Pharmacy NV ranks #9 out of 683 companies for EV-to-OCF. This places Redcare Pharmacy NV in the top 1% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 8.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.80, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redcare Pharmacy NV's current EV-to-OCF is -231.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redcare Pharmacy NV stock overvalued right now?
Based on GuruFocus' analysis, Redcare Pharmacy NV (XSWX:RDC) is currently considered Possible Value Trap. The stock's GF Value™ is CHF159.85, compared to a current price of CHF58.05 — trading 63.7% below its estimated fair value. The current EV-to-OCF is -231.95. Redcare Pharmacy NV's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Redcare Pharmacy NV (XSWX:RDC), the current EV-to-OCF is -231.95 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Redcare Pharmacy NV (XSWX:RDC) Overvalued in 2026?
Based on GuruFocus' analysis, Redcare Pharmacy NV stock appears to be undervalued.
The current stock price of CHF58.05 is trading 63.7% below its estimated GF Value™ of CHF159.85.
GuruFocus considers Redcare Pharmacy NV to be Possible Value Trap.
Key valuation signals for XSWX:RDC:
EV-to-OCF: -231.95
GF Value™: CHF159.85 vs. price of CHF58.05 (63.7% below fair value)
No single metric tells the full story. See the XSWX:RDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
46GF Score
Get the complete analysis for XSWX:RDC
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:RDC has been successfully added to your 
